Expression of the RNase III enzyme DROSHA is reduced during progression of human cutaneous melanoma

Modern Pathology

Volumn 26, Issue 7, 2013, Pages 902-910

  Jafarnejad, Seyed Mehdi ^a   Sjoestroem, Cecilia ^a   Martinka, Magdalena ^a   Li, Gang ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

DROSHA; melanoma; TMA; tumor progression

Indexed keywords

ANTIBODY; DICER; DICER1 PROTEIN; DROSHA ENZYME; MICRORNA; RIBONUCLEASE III; UNCLASSIFIED DRUG; DEAD BOX PROTEIN; DICER1 PROTEIN, HUMAN; DROSHA PROTEIN, HUMAN;

ADULT; ARTICLE; BIOGENESIS; CANCER PATIENT; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CUTANEOUS MELANOMA; CYTOPLASM; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MELANOCYTE; MELANOCYTIC NEVUS; METASTATIC MELANOMA; NEVUS; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SKIN ULCER; TISSUE MICROARRAY; TUMOR GROWTH; TUMOR VOLUME; BIOSYNTHESIS; DISEASE COURSE; ENZYMOLOGY; MELANOMA; MIDDLE AGED; SKIN TUMOR;

DEAD-BOX RNA HELICASES; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; RIBONUCLEASE III; SKIN NEOPLASMS; TISSUE ARRAY ANALYSIS;

EID: 84879991696     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2012.225     Document Type: Article

References (32)

1. Bushati N, Cohen SM. microRNA functions. Annu Rev Cell Dev Biol 2007;23:175-205.
2. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010;11:597-610.
3. Carrington JC, Ambros V. Role of microRNAs in plant and animal development. Science 2003;301:336-338. (Pubitemid 36877060)
4. Cheng AM, Byrom MW, Shelton J, et al. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 2005;33:1290-1297. (Pubitemid 41439922)
5. Chen Y, Gorski DH. Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood 2008;111:1217-1226. (Pubitemid 351213403)
6. Wilting SM, Snijders PJ, Verlaat W, et al. Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis. Oncogene 2013;32:106-116.
7. Landi MT, Zhao Y, Rotunno M, et al. MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin Cancer Res 2010;16:430-441.
8. Ozen M, Creighton CJ, Ozdemir M, et al. Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 2008;27:1788-1793. (Pubitemid 351380263)
9. Png KJ, Yoshida M, Zhang XHF, et al. MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. Gene Dev 2011;25:226-231.
10. Baer C, Claus R, Frenzel LP, et al. Extensive promoter hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia. Cancer Res 2012;72: 3775-3785.
11. Kuchen S, Resch W, Yamane A, et al. Regulation of microRNA expression and abundance during lymphopoiesis. Immunity 2010;32:828-839.
12. Faggad A, Kasajima A, Weichert W, et al. Downregulation of the microRNA processing enzyme Dicer is a prognostic factor in human colorectal cancer. Histopathology 2012; in press.
13. Merritt WM, Lin YG, Han LY, et al. Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med 2008;359:2641-2650.
14. Zhou YM, Chen LJ, Barlogie B, et al. High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2. Proc Natl Acad Sci USA 2010;107:7904-7909.
15. Caramuta S, Egyhazi S, Rodolfo M, et al. MicroRNA expression profiles associated with mutational status and survival in malignant melanoma. J Invest Dermatol 2010;130:2062-2070.
16. Xu Y, Brenn T, Brown ER, et al. Differential expression of microRNAs during melanoma progression: NiR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors. Br J Cancer 2012;106:553-561.
17. Schultz J, Lorenz P, Gross G, et al. MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorageindependent growth. Cell Res 2008;18:549-557. (Pubitemid 351630945)
18. Felicetti F, Errico MC, Bottero L, et al. The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res 2008;68: 2745-2754. (Pubitemid 351556272)
19. Jafarnejad SM, Ardekani GS, Ghaffari M, et al. Sox4-mediated Dicer expression is critical for suppression of melanoma cell invasion. Oncogene 2012; in press.
20. Guo XF, Liao QJ, Chen P, et al. The microRNAprocessing enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal carcinoma. J Cancer Res Clin 2012;138:49-56.
21. Papachristou DJ, Sklirou E, Corradi D, et al. Immunohistochemical analysis of the endoribonucleases Drosha, Dicer and Ago2 in smooth muscle tumours of soft tissues. Histopathology 2012;60:E28-E36.
22. Shu GS, Yang ZL, Liu DC. Immunohistochemical study of Dicer and Drosha expression in the benign and malignant lesions of gallbladder and their clinicopathological significances. Pathol Res Pract 2012;208:392-397.
23. Sugito N, Ishiguro H, Kuwabara Y, et al. RNASEN regulates cell proliferation and affects survival in esophageal cancer patients. Clin Cancer Res 2006;12: 7322-7328. (Pubitemid 46095404)
24. Papachristou DJ, Korpetinou A, Giannopoulou E, et al. Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas. Virchows Arch 2011;459:431-440.
25. Passon N, Gerometta A, Puppin C, et al. Expression of Dicer and Drosha in triple-negative breast cancer. J Clin Pathol 2012;65:320-326.
26. Grund SE, Polycarpou-Schwarz M, Luo C, et al. Rare Drosha splice variants are deficient in microRNA processing but do not affect general microRNA expression in cancer cells. Neoplasia 2012;14:238-248.
27. Vaksman O, Hetland TE, Trope CG, et al. Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma. Hum Pathol 2012;43:2062-2069.
28. Dedes KJ, Natrajan R, Lambros MB, et al. Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer. Eur J Cancer 2011;47:138-150.
29. Torres A, Torres K, Paszkowski T, et al. Major regulators of microRNAs biogenesis Dicer and Drosha are down-regulated in endometrial cancer. Tumour Biol 2011;32:769-776.
30. Kuehbacher A, Urbich C, Zeiher AM, et al. Role of dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res 2007;101:59-68. (Pubitemid 47094624)
31. Chong MM, Zhang G, Cheloufi S, et al. Canonical and alternate functions of the microRNA biogenesis machinery. Genes Dev 2010;24:1951-1960.
32. Oskowitz AZ, Penfornis P, Tucker A, et al. Drosha regulates hMSCs cell cycle progression through a miRNA independent mechanism. Int J Biochem Cell B 2011;43:1563-1572.